Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kazuyuki Yoshizaki is active.

Publication


Featured researches published by Kazuyuki Yoshizaki.


Ensho | 1992

Establishment of highly sensitive and wide-ranged immunoassay for TNF.ALPHA. by DELFIA.

Atsushi Ogata; Kazuyuki Yoshizaki; Hiromi Tagoh; Taeho Lee; Hakuro Ikegami; Taro Kuritani; Masashi Kurimoto; Tadamitsu Kishimoto

Non-isotopic immunoassay for the human tumor necrosis factor α (TNFα) was established by employing the dissociated enhanced lanthanide fluoroimmunoassay (DELFIA) system, based on the timeresolved fluoroimmunoassay (TR-FIA) technique utilizing the europium-labeled antibody. In comparison with enzyme-linked immunosorbent assay and bioassay, the sensitivity and range of measurement could be significantly increased by applying the DELFIA system to TNFα.Biological samples, including serum, may affect some of the immunoassays. We overcome the serum influence to the measurement of TNFα by DELFIA, Percent recovery of additional TNFα in each diluted serum was determined, then the sliding standard curve of each serum sample was mathematically calculated from the recovery. Finally corrected TNFα amount was detected by using the sliding standard curve. We suggest that more accurate, sensitive and wide ranged TNFα immunoassay has been established by DELFIA with some revising calculation.


Archive | 2001

Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist

Hiroaki Ito; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Shin Shimaoka; Hidetomo Kitamura; Masamichi Sugimoto; Kenichi Akamatsu


Archive | 2006

Blood MMP-3 level-lowering agent comprising IL-6 antagonist as active ingredient

Kazuyuki Yoshizaki; Yasunori Okada; Kenichi Obata


Archive | 2002

Remedies for infant chronic arthritis-relating diseases

Kazuyuki Yoshizaki; Masahiro Iwamoto; Seiji Minota; Shumpei Yokota; Takako Miyamae


Archive | 2007

Blood VEGF level-lowering agent containing IL-6 antagonist as the active ingredient

Kazuyuki Yoshizaki


Archive | 2007

PREVENTIVE OR THERAPEUTIC AGENT FOR PSORIASIS COMPRISING IL-6 ANTAGONIST AS ACTIVE INGREDIENT

Hiroaki Ito; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Shin Shimaoka; Hidetomo Kitamura; Masamichi Sugimoto; Kenichi Akamatsu


Arthritis & Rheumatism | 1992

Anti-interleukin-6 autoantibodies in rheumatic diseases : increased frequency in the sera of patients with systemic sclerosis

Hiroyuki Takemura; Hiroshi Suzuki; Kazuyuki Yoshizaki; Atsushi Ogata; Takamichi Yuhara; Takao Akama; Kazuhide Yamane; Heihachiro Kashiwagi


Archive | 2011

Therapeutic agent for chronic arthritides diseases of childhood-related diseases

Kazuyuki Yoshizaki; Masahiro Iwamoto; Seiji Minota; Shumpei Yokota; Takako Miyamae


Archive | 2007

Method for treating psoriasis by administering an antibody to interleukin-6 receptor

Hiroaki Ito; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Shin Shimaoka; Hidetomo Kitamura; Masamichi Sugimoto; Kenichi Akamatsu


Archive | 2011

Method of treating psoriatic arthritis with an IL-6 receptor antibody

Hiroaki Ito; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Shin Shimaoka; Hidetomo Kitamura; Masamichi Sugimoto; Kenichi Akamatsu

Collaboration


Dive into the Kazuyuki Yoshizaki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shin Shimaoka

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takako Miyamae

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Seiji Minota

Jichi Medical University

View shared research outputs
Top Co-Authors

Avatar

Shumpei Yokota

Yokohama City University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge